Drugplain

CLENZIDERM PORE THERAPY ACNE TREATMENT 20 mg/mL

SALICYLIC ACID · LIQUID · Obagi Cosmeceuticals LLC

No Recall History
Plain English

CLENZIDERM PORE THERAPY ACNE TREATMENT is a liquid containing salicylic acid at 20 mg/mL, taken topical. Manufactured by Obagi Cosmeceuticals LLC.

Key Facts

Brand Name
CLENZIDERM PORE THERAPY ACNE TREATMENT
Generic Name
SALICYLIC ACID
NDC Code (Product)
62032-612
Manufacturer
Obagi Cosmeceuticals LLC
Strength
20 mg/mL
Dosage Form
LIQUID
Route
TOPICAL
Marketing Status
Application #
M006
Marketing Start
02/01/2007

Recall History

No Recall History

Frequently Asked Questions

What is CLENZIDERM PORE THERAPY ACNE TREATMENT used for?

CLENZIDERM PORE THERAPY ACNE TREATMENT contains SALICYLIC ACID. It is a liquid taken topical. Consult your doctor for specific uses.

Is CLENZIDERM PORE THERAPY ACNE TREATMENT a controlled substance?

CLENZIDERM PORE THERAPY ACNE TREATMENT is not classified as a controlled substance by the DEA.

What is the generic name for CLENZIDERM PORE THERAPY ACNE TREATMENT?

The generic name for CLENZIDERM PORE THERAPY ACNE TREATMENT is SALICYLIC ACID. There are 12 other brand versions of SALICYLIC ACID.

What is the NDC code for CLENZIDERM PORE THERAPY ACNE TREATMENT 20 mg/mL?

The NDC (National Drug Code) for CLENZIDERM PORE THERAPY ACNE TREATMENT 20 mg/mL is 62032-612, listed by Obagi Cosmeceuticals LLC.